The global Live Attenuated Influenza Vaccine (LAIV) market size is predicted to grow from US$ 8858 million in 2025 to US$ 12950 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
Key Features
- Evolving Vaccine Formulations
- Preference for Non-Invasive Vaccination
- Efficacy and Effectiveness Research
- Enhanced Cold Chain Management
- Global Variations in Approval
Segmentation by Type
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
Segmentation by Application
- Hospital
- Clinic
- Public Health Agency
- Other
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Companys Coverage
- Sanofi Pasteur
- AstraZeneca
- CSL
- Abbott
- GlaxoSmithKline
- Serum Institute
- Fluenz Tetra
- Cytiva
- BioDiem
- FluMist
- GSK
- ChangChun High & New Technology
- BCHT Biotechnology
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Live Attenuated Influenza Vaccine (LAIV) market?
- What factors are driving Live Attenuated Influenza Vaccine (LAIV) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Live Attenuated Influenza Vaccine (LAIV) market opportunities vary by end market size?
- How does Live Attenuated Influenza Vaccine (LAIV) break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
Live Attenuated Influenza Vaccine (LAIV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Live Attenuated Influenza Vaccine (LAIV) report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Live Attenuated Influenza Vaccine (LAIV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.